Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Similar documents
Hematopathology Case Study

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

Myelodysplastic Syndrome Case 158

Case Presentation No. 075

Bone Marrow Pathology. Part 1. R.S. Riley, M.D., Ph.D.

Morfologia normale e patologica

20/20 PATHOLOGY REPORTS

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS

Hematology Unit Lab 2 Review Material

2013 AAIM Pathology Workshop

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

Mild Megakaryocyte Atypia in a Patient with Presumed Germline GATA2 Mutation, and Active Mycobacterial Infection.

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Juvenile Myelomonocytic Leukemia (JMML)

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0.

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HEMATOPATHOLOGY SUMMARY REPORT RL;MMR;

Chronic Myelomonocytic Leukemia with molecular abnormalities SH

Blood Cell Identification Graded

Heme 9 Myeloid neoplasms

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

Blood Cell Identification Graded

SESSION 1 Reactive cytopenia and dysplasia

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016

2 nd step do Bone Marrow Study If possible both the aspiration and

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal/

ACCME/Disclosures. History. Hematopathology Specialty Conference Case #4 4/13/2016

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

Introduction. Indications for bone marrow examination. Obtaining the bone marrow biopsy

EXAMPLE REPORT ONLY Contact AMS Biotechnology for current donor specific information

Notes for the 2 nd histology lab

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow

MORPHOLOGY IN ACTION. Description MINI-CASE ONE OBJECTIVES. Differential Diagnosis. Laboratory Results

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Hematopathology Case Study

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY

CHALLENGING CASES PRESENTATION

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

Blood Cell Identification Graded

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Faculty of Medicine Dr. Tariq Aladily

EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION

Case #1. 65 yo man with no prior history presented with leukocytosis and circulating blasts: Bone marrow biopsy was performed

Polycthemia Vera (Rubra)

2007 Workshop of SH/EAHP. Session 5 Therapy-related myeloid neoplasms

Blood Cell Identification Graded

Extramedullary precursor T-lymphoblastic transformation of CML at presentation

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

MDS: Who gets it and how is it diagnosed?

Hematology Measure #1: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester

Myelodysplastic Syndrome: Let s build a definition

Cbc with differential

EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES

Year 2003 Paper two: Questions supplied by Tricia

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP

Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms Involving the Bone Marrow*

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

FLOW CYTOMETRIC ANALYSIS OF NORMAL BONE MARROW

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Hematopathology Lab. Third year medical students

BLASTIC CRISIS AND MYELOFIBROSIS SIMULTANEOUS COMPLICATIONS IN A CASE OF CHRONIC MYELOCYTIC LEUKEMIA

Presented by: Dr. Giuseppe Molinaro Dr. Davide De Biase

Detection and Classification of Acute Leukemia by the Coulter STKS Hematology Analyzer

Bone Marrow Evaluation of cases of Leukemia in Pathology Department, BJGMC, Pune

Hematology & Coagulation Practicum Objectives CLS - 647

Adult Acute leukemia. Matthew Seftel. August

Proper Slide Preparation

Leukocytosis - Some Learning Points

بسم هللا الرحمن الرحيم

Myelodysplastic/Myeloproliferative Disorders. MDS/MPD Unclassified Provisional: CMML JMML acml RARS T. K. Foucar November 2007 SH/EAHP Workshop

EDUCATIONAL COMMENTARY DIFFERENTIATING IMMATURE PERIPHERAL BLOOD CELLS

Aplastic Anemia & MDS International Foundation Talk. Definition. Introduction 4/20/2012. April 2012 H. Phillip Koeffler, M.D.

The spectrum of flow cytometry of the bone marrow

Bone marrow evaluation is an important diagnostic tool for evaluating

CD34 positive dysplastic giant platelets masquerading as blasts on flow cytometry

Opportunities for Optimal Testing in the Myeloproliferative Neoplasms. Curtis A. Hanson, MD

SB 6331 (scanned slide available) Keith Duncan; Mills-Peninsula Hospital 52-year-old male with painful right parotid mass.

COMPANY OR UNIVERSITY

Update on Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Kaaren Reichard Mayo Clinic Rochester

ACCME/Disclosures 4/13/2016. Clinical History

Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study

Transcription:

HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular bone marrow with morphologically normal trilineage hematopoiesis. Case Number BR-17-1330 2. No morphologic features of a myelodysplastic syndrome, a myeloproliferative neoplasm, or other primary malignant myeloid neoplasms. 3. No morphologic or immunophenotypic features of involvement by lymphoma. COMMENT The etiology of the patient's mild cytopenia is not evident from this bone marrow examination. Secondary causes such as toxic exposure, medication/drug usage, alcohol consumption, nutrional deficiency, autoimmune disorders, chronic inflammation/infection, should be considered. Correlation with cytogenetic and Next Generation Sequencing findings is suggested. MICROSCOPIC DESCRIPTION Peripheral Blood By report CBC (dated 6/22/17): Hgb 10.6 g/dl; RBC 3.56 X10(12)/L; MCV 86.2 fl; RDW 16.2 %; WBC 3.9 x10(9)/l; PLT 369 x 10(9)/L. NEUTROPHILS 62 MONOCYTES 16 EOSINOPHILS 0 METAMYELOCYTES 0 MYELOCYTES 0 BLASTS 0 OTHER CELLS 0 NRBC 0 Total s: 100 Peripheral smear: Red blood cells: White blood cells: % of Total s BR-17-1330 Page 1 of 6

Client Platelets: Bone Marrow Aspirate/Touch Imprint NEUTROPHILS 26 METAMYELOCYTES 7 MYELOCYTES 7 EOSINOPHILS 9 BLASTS 6 NORMOBLASTS 0 PROMONOCYTES 0 MONOCYTES 23 PLASMA CELLS 0 Total s: 100 Quality: ular M:E ratio: 2:3 Erythroid precursors: Normoblastic maturation. Myeloid precursors: Normal maturation without dysplastic features. Blasts not increased. Megakaryocytes: Normal cytology Lymphocytes: Not increased. Bone Marrow Biopsy/Clot Quality: Adequate ularity: Normal; 40%. Erythroid precursors: Relatively slightly increased with normal morphology. % of Total s BR-17-1330 Page 2 of 6

Client Myeloid Precursors: Relatively slightly decreased with normal morphology. Blasts not increased. Megakaryocytes: Normal quantity and morphology. Lymphocytes: No lymphoid aggregates. ANCILLARY STUDIES Iron stain, bone marrow aspirate: performed at Mayo Clinic in Rochester, MN: Storage slightly increased. Sideroblasts present. Ring sideroblasts not seen. Cytochemical stain, myeloperoxidase, bone marrow aspirate myeloperoxidase is positive. Cytochemical stain, butyrate esterase/chloroacetate esterase, bone marrow aspirate butyrate esterase is positive and chloroacetate is negative. Immunohistochemical studies, bone marrow biopsy, antibodies to CD30 and Ki67: The cells are negative for CD30 and negative for Ki67. REVISION DESCRIPTION Report reactivated to update Ancillary Studies. In Ancillary Studies the CD30 result was updated from positive to be negative. Gross Description Report electronically signed by ANGELA REESE-DAVIS I verify that I have examined all relevant slides/materials for the specimen(s) and rendered or confirmed the diagnosis. B: Received in formalin labeled with the patient's name, medical record number and "Bone marrow biopsy" is a 1.0 x 0.2 cm core of tissue. The specimen is submitted en toto in cassette #1.C: Received in formalin labeled with the patient's name, medical record number and "Bone marrow clot" is a 1.0 x 0.5 x 0.2 cm aggregate of tissue. The specimen is submitted en toto in cassette #1. Material Received A. BM654: Bone marrow 8 unstained slides B. BM654: biopsy C. BM654: clot Received: 23 Jun 2017 11:46 Reported: 29 Jun 2017 14:27 BR-17-1330 Page 3 of 6

Client Previously Reported As: Hematopathology Consult Interpretation Previously reported on 26 Jun 2017 at 12:27 as: INAL DIAGNOSIS Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular bone marrow with morphologically normal trilineage hematopoiesis. 2. No morphologic features of a myelodysplastic syndrome, a myeloproliferative neoplasm, or other primary malignant myeloid neoplasms. 3. No morphologic or immunophenotypic features of involvement by lymphoma. COMMENT The etiology of the patient's mild cytopenia is not evident from this bone marrow examination. Secondary causes such as toxic exposure, medication/drug usage, alcohol consumption, nutrional deficiency, autoimmune disorders, chronic inflammation/infection, should be considered. Correlation with cytogenetic and Next Generation Sequencing findings is suggested. MICROSCOPIC DESCRIPTION Peripheral Blood By report CBC (dated 6/22/17): Hgb 10.6 g/dl; RBC 3.56 X10(12)/L; MCV 86.2 fl; RDW 16.2 %; WBC 3.9 x10(9)/l; PLT 369 x 10(9)/L. NEUTROPHILS 62 MONOCYTES 16 EOSINOPHILS 0 % of Total s BR-17-1330 Page 4 of 6

Client METAMYELOCYTES 0 MYELOCYTES 0 BLASTS 0 OTHER CELLS 0 NRBC 0 Total s: 100 Peripheral smear: Red blood cells: White blood cells: Platelets: Bone Marrow Aspirate/Touch Imprint NEUTROPHILS 26 METAMYELOCYTES 7 MYELOCYTES 7 EOSINOPHILS 9 BLASTS 6 NORMOBLASTS 0 PROMONOCYTES 0 MONOCYTES 23 PLASMA CELLS 0 Total s: 100 Quality: ular M:E ratio: 2:3 % of Total s Erythroid precursors: Normoblastic maturation. BR-17-1330 Page 5 of 6

Client Myeloid precursors: Normal maturation without dysplastic features. Blasts not increased. Megakaryocytes: Normal cytology Lymphocytes: Not increased. Bone Marrow Biopsy/Clot Quality: Adequate ularity: Normal; 40%. Erythroid precursors: Relatively slightly increased with normal morphology. Myeloid Precursors: Relatively slightly decreased with normal morphology. Blasts not increased. Megakaryocytes: Normal quantity and morphology. Lymphocytes: No lymphoid aggregates. ANCILLARY STUDIES Iron stain, bone marrow aspirate: performed at Mayo Clinic in Rochester, MN: Storage slightly increased. Sideroblasts present. Ring sideroblasts not seen. Cytochemical stain, myeloperoxidase, bone marrow aspirate myeloperoxidase is positive. Cytochemical stain, butyrate esterase/chloroacetate esterase, bone marrow aspirate butyrate esterase is positive and chloroacetate is negative. Immunohistochemical studies, bone marrow biopsy, antibodies to CD30 and Ki67: The cells are positive for CD30 and negative for Ki67. BR-17-1330 Page 6 of 6